Devyser (private company)

See something wrong or missing? Let us know
Offices:Stockholm
Business model:B2B

Devyser develops diagnostic kits for complex DNA testing within oncology, reproductive health and hereditary diseases.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 1.69M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Devyser

Name Criteria
Norway Bio-Me
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Denmark Octarine Bio
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Sano Genetics
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Sigrid Therapeutics
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Finland Sooma Medical
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Pila Pharma
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France PEP-Therapy
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Nanolyze
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Clustermarket
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Germany Atai Life Sciences
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
Top